Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1975 Apr;34(2):162–165. doi: 10.1136/ard.34.2.162

Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis.

D P Bajpayee
PMCID: PMC1006365  PMID: 49178

Abstract

To understand the role of copper in initiating protein alterations in rheumatoid arthritis (RA) as reported previously, concentrations of copper anc caeruloplasmin were determined in RA patients. The mean copper concentration of the RA population examined was 24.8 mumol/l (157.5 mug/100 ml), and the mean caeruloplasmin concentration in this RA population was 45.52 mg/100 ml. These values are not different from those reported by previous workers. However, when the RA population was divided into three groups according to sex and oestrogen therapy it was found that caeruloplasmin and copper concentrations in the group of female RA patients on oestrogens was significantly different from other groups (P less than 0.001). A highly significant (P less than 0.01) positive correlation was obtained between copper and caeruloplasmin concentrations (r = 0.91). Concentrations of copper and caeruloplasmin failed to explain the low sulphydryl content of plasma which was observed to be independent of these two parameters. Increased alpha2-globulin concentration, which was refractory to chrysotherapy but 'finger-printed' with a pure preparation of caeruloplasmin in electrophoresis, along with the absence of Kayser-Fleischer rings, supports the contention that copper is not present in a free ionic state in RA patients. This study shows that only a concurrent oestrogen therapy raises copper and caeruloplasmin concentration significantly in a female RA population. Past investigators appear to have overlooked this fact, and it could be that a disproportionate sex distribution (more female rheumatoid arthritics) could cause misleading results in RA studies. The role of oestrogens, copper, and caeruloplasmin in causing exacerbation of RA symptoms is discussed.

Full text

PDF
162

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carruthers M. E., Hobbs C. B., Warren R. L. Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives. J Clin Pathol. 1966 Sep;19(5):498–500. doi: 10.1136/jcp.19.5.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cumings J. N. Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses). Proc R Soc Med. 1971 Mar;64(3):313–322. doi: 10.1177/003591577106400335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ELLMAN G. L. A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys. 1958 Apr;74(2):443–450. doi: 10.1016/0003-9861(58)90014-6. [DOI] [PubMed] [Google Scholar]
  4. LORBER A., PEARSON C. M., MEREDITH W. L., GANTZ-MANDELL L. E. SERUM SULFHYDRYL DETERMINATIONS AND SIGNIFICANCE IN CONNECTIVE TISSUE DISEASES. Ann Intern Med. 1964 Sep;61:423–434. doi: 10.7326/0003-4819-61-3-423. [DOI] [PubMed] [Google Scholar]
  5. Lorber A., Cutler L. S., Chang C. C. Serum copper levels in rheumatoid arthritis: relationship of elevated copper to protein alterations. Arthritis Rheum. 1968 Feb;11(1):65–71. doi: 10.1002/art.1780110109. [DOI] [PubMed] [Google Scholar]
  6. NICOL T., BILBEY D. L., CHARLES L. M., CORDINGLEY J. L., VERNON-ROBERTS B. OESTROGEN: THE NATURAL STIMULANT OF BODY DEFENCE. J Endocrinol. 1964 Oct;30:277–291. doi: 10.1677/joe.0.0300277. [DOI] [PubMed] [Google Scholar]
  7. Nicol T., Vernon-Roberts B., Quantock D. C. The effects of oestrogen: androgen interaction on the reticulo-endothelial system and reproductive tract. J Endocrinol. 1966 Feb;34(2):163–178. doi: 10.1677/joe.0.0340163. [DOI] [PubMed] [Google Scholar]
  8. Niedermeier W. Concentration and chemical state of copper in synovial fluid and blood serum of patients with rheumatoid arthritis. Ann Rheum Dis. 1965 Nov;24(6):544–548. doi: 10.1136/ard.24.6.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Niedermeier W., Griggs J. H. Trace metal composition of synovial fluid and blood serum of patients with rheumatoid arthritis. J Chronic Dis. 1971 Jan;23(8):527–536. doi: 10.1016/0021-9681(71)90128-7. [DOI] [PubMed] [Google Scholar]
  10. O'Leary J. A. Serum copper levels as a measure of placental function. Am J Obstet Gynecol. 1969 Oct 15;105(4):636–637. [PubMed] [Google Scholar]
  11. O'Leary J. A., Spellacy W. N. Zinc and copper levels in pregnant women and those taking oral contraceptives. A preliminary report. Am J Obstet Gynecol. 1969 Jan 1;103(1):131–132. doi: 10.1016/s0002-9378(16)34354-x. [DOI] [PubMed] [Google Scholar]
  12. PLANTIN L. O., STRANDBERG P. O. WHOLE-BLOOD CONCENTRATIONS OF COPPER AND ZINC IN RHEUMATOID ARTHRITIS STUDIED BY ACTIVATION ANALYSIS. Acta Rheumatol Scand. 1965;11:30–34. doi: 10.3109/rhe1.1965.11.issue-1-4.05. [DOI] [PubMed] [Google Scholar]
  13. SAROFF H. A., CHOATE W. L. Reversible aggregation of serum albumin in the reaction with copper (II). Arch Biochem Biophys. 1958 Mar;74(1):245–251. doi: 10.1016/0003-9861(58)90217-0. [DOI] [PubMed] [Google Scholar]
  14. SCHEINBERG I. H., MORELL A. G. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease. J Clin Invest. 1957 Aug;36(8):1193–1201. doi: 10.1172/JCI103515. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES